Pharma Firms Get Re-Patriotic As Foreign Tax Break Moves Through Congress
This article was originally published in The Tan Sheet
Executive Summary
Supporters of a provision beneficial to the pharmaceutical industry allowing U.S. firms to repatriate income from foreign subsidiaries at a significantly reduced tax rate will have to wait until after the July 4 recess to revisit the legislation